Review of the management of adverse effects associated with ...

Recommendation 3
Improving the National System for Timely
Reporting of Adverse Events Following
Immunisation
That the Department requests the TGA to
establish a joint TGA/National Immunisation
Committee working group to develop
mechanisms for improved and timely information
flows between TGA and the jurisdictions and
agreed templates for nationally consistent
reporting of adverse events following
immunisation.
Recommendation 4
Raising Community and Health Professional
Awareness of Vaccine Safety Monitoring to
Ensure More Complete Reporting of Adverse
Events Following Immunisation
That the Department considers the development
of a communications strategy to inform
jurisdictions, health professionals and consumers
of the vaccine safety monitoring processes in
Australia.
Recommendation 5
Nationally Agreed Protocols for Program Action
and Communication
That the Department develops and agrees
with jurisdictions a protocol for taking program
action, including informing health professionals,
consumers and the media, in the event a possible
safety signal is detected affecting a National
Immunisation Program vaccine.
Recommendation 6
Transparency and the Functions of the TGA
to Ensure Better Access to Vaccine Safety
Information for Consumers and Health
Professionals
Improvements to the transparency of the TGA’s
vaccine safety monitoring processes should be
considered by the independent Transparency
Review of the TGA being chaired by Professor
Dennis Pearce.
Recommendation 7
Vaccine Usage and Safety Monitoring Data
The collection of vaccine usage and safety
monitoring data should be a key priority for future
e-health planning and development.
36
Review of the management of adverse events associated with Panvax and Fluvax